|
|
Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia
Philipp Staber
,
Marco Herling
,
Mar Bellido
,
Eric Jacobsen
,
Matthew Davids
,
et al.
Journal articles
hal-02318820v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Chronic T cell receptor stimulation unmasks NK receptor signaling in peripheral T cell lymphomas via epigenetic reprogramming
Sylvain Carras
,
Dimitri Chartoire
,
Sylvain Mareschal
,
Maël Heiblig
,
Antoine Marçais
,
et al.
Journal articles
inserm-03280949v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Outcome after hematopoietic stem cell transplantation in patients with extranodal natural killer/ T‐Cell lymphoma, nasal type: A French study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire ( SFGM‐TC )
Laure Philippe Walter
,
Lucile Couronné
,
Jean‐philippe Jais
,
Phong‐dinh Nguyen
,
Didier Blaise
,
et al.
Journal articles
hal-03623641v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Molecular Classification of Diffuse Large B-cell Lymphoma: What Is Clinically Relevant?
Pierre Sujobert
,
Gilles Salles
,
Emmanuel Bachy
Journal articles
hal-01800003v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Clinicopathological features and survival in EBV-positive diffuse large B-cell lymphoma not otherwise specified
Estelle Bourbon
,
Delphine Maucort-Boulch
,
Juliette Fontaine
,
Claire Mauduit
,
Pierre Sesques
,
et al.
Journal articles
hal-04151083v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Clinical characteristics and outcomes of relapsed follicular lymphoma after autologous stem cell transplantation in the rituximab era
Pierre Sesques
,
Jessie Bourcier
,
Camille Golfier
,
Laure Lebras
,
Emmanuelle Nicolas‐virelizier
,
et al.
Journal articles
inserm-03496368v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Droplet digital PCR allows vector copy number assessment and monitoring of experimental CAR T cells in murine xenograft models or approved CD19 CAR T cell-treated patients
Rafik Haderbache
,
Walid Warda
,
Eric Hervouet
,
Mathieu Neto da Rocha
,
Rim Trad
,
et al.
Journal articles
hal-03443941v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Comparative toxicities of 3 platinum-containing chemotherapy regimens in relapsed/refractory lymphoma patients: Platinum-containing chemotherapy regimens
F. Tixier
,
F. Ranchon
,
A. Iltis
,
N. Vantard
,
V. Schwiertz
,
et al.
Journal articles
hal-01796180v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Long-Term Follow-Up of Patients With Newly Diagnosed Follicular Lymphoma in the Prerituximab Era: Effect of Response Quality on Survival--A Study From the Groupe d'Etude des Lymphomes de l'Adulte.
Emmanuel Bachy
,
Pauline Brice
,
Richard Delarue
,
Nicole Brousse
,
Corinne Haioun
,
et al.
Journal articles
hal-00453229v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
L’émergence des traitements par cellules CAR-T dans les lymphomes
Gilles Salles
,
Pierre Sesques
,
Emmanuelle Ferrant
,
Violaine Safar
,
Hervé Ghesquieres
,
et al.
Journal articles
hal-03486656v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low–Tumor Burden Follicular Lymphoma: Results of a LYSA Study
Guillaume Cartron
,
Emmanuel Bachy
,
Hervé Tilly
,
Nicolas Daguindau
,
Gian-Matteo Pica
,
et al.
Journal articles
hal-04212199v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma
François Lemonnier
,
Violaine Safar
,
Asma Beldi-Ferchiou
,
Anne-Ségolène Cottereau
,
Emmanuel Bachy
,
et al.
Journal articles
hal-03226483v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Outcomes of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T analysis
Roberta Di Blasi
,
Steven Le Gouill
,
Emmanuel Bachy
,
Guillaume Cartron
,
David Beauvais
,
et al.
Journal articles
hal-03903472v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Array-CGH predicts prognosis in plasma cell post-transplantation lymphoproliferative disorders
Clémentine Sarkozy
,
Sophie Kaltenbach
,
Pierre Faurie
,
Danielle Canioni
,
Françoise Berger
,
et al.
Journal articles
hal-01795702v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Éligibilité des patients aux cellules CAR-T : avis d’experts proposé par la SFGM-TC
David Beauvais
,
Emmanuel Bachy
,
André Baruchel
,
Jacques-Olivier Bay
,
Denis Caillot
,
et al.
Journal articles
inserm-03349011v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Controversies in the Treatment of Peripheral T-cell Lymphoma
Emmanuel Bachy
,
Alessandro Broccoli
,
Claire Dearden
,
Laurence de Leval
,
Philippe Gaulard
,
et al.
Journal articles
hal-04215545v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Maintaining calcineurin inhibition after the diagnosis of post-transplant lymphoproliferative disorder improves renal graft survival
Jean-Emmanuel Serre
,
David Michonneau
,
Emmanuel Bachy
,
Laure-Hélène Noël
,
Valérie Dubois
,
et al.
Journal articles
hal-01911491v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study.
Emilie Reboursiere
,
Fabien Le Bras
,
Charles Herbaux
,
Emmanuel Gyan
,
Aline Clavert
,
et al.
Journal articles
hal-01475957v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
CD1d-restricted peripheral T cell lymphoma in mice and humans
Emmanuel Bachy
,
Mirjam Urb
,
Shilpi Chandra
,
Rémy Robinot
,
Gabriel Bricard
,
et al.
Journal articles
hal-01305487v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Long-term outcomes of adults with first-relapsed/refractory systemic anaplastic large-cell lymphoma in the pre-brentuximab vedotin era: A LYSA/SFGM-TC study
Alexandre Morel
,
Josette Brière
,
Laurence Lamant
,
Michael Loschi
,
Corinne Haioun
,
et al.
Journal articles
hal-01655967v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Statin use is safe and does not impact prognosis in patient with de novo follicular lymphoma treated with immunochemotherapy: An exploratory analysis of the PRIMA cohort study
Emmanuel Bachy
,
Jane A. Estell
,
Eric van De Neste
,
Reda Bouabdallah
,
Joan Bargay
,
et al.
Journal articles
hal-01263105v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Post-transplantation Burkitt lymphoma: a retrospective study of 55 patients
Pierre Walczak
,
Sylvain Choquet
,
Jacques Dantal
,
David Boutboul
,
Felipe Suarez
,
et al.
Journal articles
hal-04212687v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Axicabtagene ciloleucel in large B cell lymphoma ineligible for autologous stem cell transplantation: the phase 2 ALYCANTE trial
Roch Houot
,
Emmanuel Bachy
,
Guillaume Cartron
,
François-Xavier Gros
,
Franck Morschhauser
,
et al.
Journal articles
hal-04212634v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
B-cell malignancies and COVID-19: a narrative review
David Luque-Paz
,
Pierre Sesques
,
Florent Wallet
,
Emmanuel Bachy
,
Florence Ader
Journal articles
hal-03955801v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMO
Irit Avivi
,
Luca Arcaini
,
Virginia Ferretti
,
Ariane Boumendil
,
Hervé Finel
,
et al.
Journal articles
hal-01841287v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Refractory diffuse large B-cell lymphoma after first-line immuno-CT: Treatment options and outcomes
Lauriane Filliatre-Clement
,
Delphine Maucort-Boulch
,
Estelle Bourbon
,
Lionel Karlin
,
Violaine Safar
,
et al.
Journal articles
hal-04151954v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Assessment of Patient Reported Outcomes (PROs) in Outpatients Taking Oral Anticancer Drugs Included in the Real-Life Oncoral Program
Bastien Collomb
,
Amélie Dubromel
,
Anne Gaëlle Caffin
,
Chloé Herledan
,
Virginie Larbre
,
et al.
Journal articles
hal-04150994v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
HLA-DR expression on monocytes and outcome of anti-CD19 CAR T-cell therapy for large B-cell lymphoma
Estelle Bourbon
,
Pierre Sesques
,
Morgane Gossez
,
Jérémie Tordo
,
Emmanuelle Ferrant
,
et al.
Journal articles
inserm-04028897v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Brentuximab vedotin in refractory or relapsed peripheral T-cell lymphomas: the French named patient program experience in 56 patients
Mathilde Lamarque
,
Céline Bossard
,
Adrien Contejean
,
Pauline Brice
,
Marie Parrens
,
et al.
Journal articles
inserm-01419525v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study
Adèle de Masson
,
Marie Beylot-Barry
,
Caroline Ram-Wolff
,
Jean-Baptiste Mear
,
Stéphane Dalle
,
et al.
Journal articles
hal-04209846v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|